The Commission has adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry. Europe’s Pharmaceutical Strategy has four main objectives: Ensuring access to affordable medicines for patients, and addressing unmet medical needs (e.g. in the […]
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19
The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure – Veterinary (CMDv) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic. According to the jointly developed question-and-answer (Q&A) document, regulatory rules […]
European Medicines Agency (EMA)
Access to the official webpage and the social networks Role: EMA guarantees the scientific evaluation, supervision & safety monitoring of human & veterinary medicines in the EU. Executive Director: Emer Cooke Established in: 1995 Number of staff: 897 Location: Amsterdam (the Netherlands) Website: EMA The European Medicines Agency (EMA) protects and promotes human and animal health […]